3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
5
Brain Neoplasms
2
Triple Negative Breast Neoplasms
1
Solid Tumor, Adult
1
Meningeal Neoplasms
1
Breast Cancer Metastatic
1
Interventions
Trastuzumab
4
tucatinib
3
Capecitabine
3
fludarabine
2
Spinal Puncture
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
pertuzumab
1
patritumab deruxtecan
1
omburtamab I-131
1
gadopiclenol
1
gadobutrol
1
fludarabine phosphate
1
avelumab
1
aldesleukin
1
WP 744
1
Temozolomide
1
Specimen Handling
1
Rituximab
1
Radiotherapy
1
Phlebotomy
1
Methotrexate
1
Mesna
1
Interleukin-2
1
Blood Specimen Collection
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Meningeal Neoplasms
×
patritumab deruxtecan
×
Clear all
NCT05865990
2026-05-04
TUXEDO-3
MedSIR
Phase 2
Completed
63 enrolled